Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionPerceptive Advisors Llc
ManagerJoseph Edelman
Latest Disclosed Ownership80,956 shares
Latest Disclosed Value $ 3,256,860
Perceptive Advisors Llc ownership in APLS / Apellis Pharmaceuticals, Inc.

On May 29, 2026 - Perceptive Advisors Llc filed a 13F-HR/A form disclosing ownership of 80,956 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $3,256,860 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2023 disclosing 0 shares of Apellis Pharmaceuticals, Inc.. The current value of the position is $3,321,625 USD.

Perceptive Advisors Llc has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 80,956 80,956 3,257 0.0636
2026-05-15 2026-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 80,956 80,956 3,257 0.0637
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -812,037 -100.00 0 -100.00
2023-08-24 2023-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 812,037 256,693 46.22 73,977 101.95 2.1412
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 812,037 256,693 73,977 2.1446
2023-05-16 2023-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 555,344 555,344 36,630 1.0815
2023-05-15 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 555,344 555,344 36,630 0.9534
2023-02-14 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -366,400 -100.00 0 -100.00
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 366,400 45,100 14.04 25,025 72.24 0.7263
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 321,300 -1,160,400 -78.32 14,529 -80.70 0.4551
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,481,700 30,000 2.07 75,285 9.69 1.5080
2022-05-04 2021-12-31 13F/A-2 APELLIS PHARMACEUTICALS COM 03753U106 1,451,700 836,700 136.05 68,636 238.61 1.0578
2022-04-13 2021-12-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 1,451,700 836,700 68,636 1.0597
2022-02-14 2021-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,451,700 836,700 68,636 1.0591
2021-12-03 2021-09-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 615,000 -46,162 -6.98 20,270 -51.49 0.2944
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 615,000 -46,162 20,270 0.2943
2021-08-17 2021-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 661,162 661,162 41,785 0.5422
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 661,162 661,162 41,785 0.5433
2020-11-16 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -11,418 -100.00 0 -100.00
2020-08-17 2020-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 11,418 0 0.00 373 14.07 0.0060
2020-08-14 2020-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 11,418 0 373 6,058.6274
2020-05-18 2020-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 11,418 11,418 327 0.0085
2020-05-15 2020-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 11,418 327 0.0085
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-26 2023-12-31 13F/A APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM Put 100,000 72 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.